Horizon Pharma | HZNP - Sales Revenues


Horizon Pharma reported $944.96M in Sales Revenues for its fiscal quarter ending in June of 2023.



Sales Change Date
AbbVie USD 16.62B 840M Dec/2025
ALKERMES USD 384.5M 9.7M Dec/2025
Amgen USD 9.9B 340M Dec/2025
AstraZeneca USD 15.5B 313M Dec/2025
Bausch Health Companies USD 2.8B 120M Dec/2025
Bristol-Myers Squibb USD 12.5B 300M Dec/2025
Cara Therapeutics USD 2.57M 1.11M Mar/2025
Coherus Biosciences USD 12.75M 1.18M Dec/2025
Eli Lilly USD 19.3B 1.7B Dec/2025
Merck USD 16.4B 880M Dec/2025
Novartis USD 13.86B 50M Dec/2025
Pacira USD 196.87M 17.35M Dec/2025
Perrigo USD 1.11B 70M Dec/2025
Pfizer USD 17.58B 880M Dec/2025
Prestige Brands USD 283.44M 9.34M Dec/2025
Supernus Pharmaceuticals USD 211.6M 19.5M Dec/2025
Takeda JPY 1.19T 80B Dec/2025
Xeris Pharmaceuticals USD 85.81M 11.43M Dec/2025
Zoetis USD 2.4B 0 Dec/2025